TY - JOUR
T1 - Gut-liver axis: barriers and functional circuits
AU - Pabst, O.
AU - Hornef, M.W.
AU - Schaap, F.G.
AU - Cerovic, V.
AU - Clavel, T.
AU - Bruns, T.
N1 - Funding Information:
The authors were supported by the German Research Foundation (DFG) Project-ID 403224013 – SFB 1382.
Publisher Copyright:
© 2023, Springer Nature Limited.
PY - 2023/7
Y1 - 2023/7
N2 - The gut and the liver are characterized by mutual interactions between both organs, the microbiome, diet and other environmental factors. The sum of these interactions is conceptualized as the gut–liver axis. In this Review we discuss the gut–liver axis, concentrating on the barriers formed by the enterohepatic tissues to restrict gut-derived microorganisms, microbial stimuli and dietary constituents. In addition, we discuss the establishment of barriers in the gut and liver during development and their cooperative function in the adult host. We detail the interplay between microbial and dietary metabolites, the intestinal epithelium, vascular endothelium, the immune system and the various host soluble factors, and how this interplay establishes a homeostatic balance in the healthy gut and liver. Finally, we highlight how this balance is disrupted in diseases of the gut and liver, outline the existing therapeutics and describe the cutting-edge discoveries that could lead to the development of novel treatment approaches.
AB - The gut and the liver are characterized by mutual interactions between both organs, the microbiome, diet and other environmental factors. The sum of these interactions is conceptualized as the gut–liver axis. In this Review we discuss the gut–liver axis, concentrating on the barriers formed by the enterohepatic tissues to restrict gut-derived microorganisms, microbial stimuli and dietary constituents. In addition, we discuss the establishment of barriers in the gut and liver during development and their cooperative function in the adult host. We detail the interplay between microbial and dietary metabolites, the intestinal epithelium, vascular endothelium, the immune system and the various host soluble factors, and how this interplay establishes a homeostatic balance in the healthy gut and liver. Finally, we highlight how this balance is disrupted in diseases of the gut and liver, outline the existing therapeutics and describe the cutting-edge discoveries that could lead to the development of novel treatment approaches.
KW - CHAIN FATTY-ACIDS
KW - FECAL MICROBIOTA TRANSPLANTATION
KW - INTESTINAL MICROBIOTA
KW - BILE-ACIDS
KW - BACTERIAL TRANSLOCATION
KW - OBETICHOLIC ACID
KW - HEPATOCELLULAR-CARCINOMA
KW - LYMPH-NODES
KW - T-CELLS
KW - DISEASE
U2 - 10.1038/s41575-023-00771-6
DO - 10.1038/s41575-023-00771-6
M3 - (Systematic) Review article
C2 - 37085614
SN - 1759-5045
VL - 20
SP - 447
EP - 461
JO - Nature Reviews Gastroenterology & Hepatology
JF - Nature Reviews Gastroenterology & Hepatology
IS - 7
ER -